MSc. Biologist and Doctoral Student, Institute of Biomedical Sciences, Laboratory of Molecular Microbiology, Universidade Federal de Uberlândia (UFU), Uberlândia (MG), Brazil.
MSc. Nurse, Institute of Biomedical Sciences, Laboratory of Molecular Microbiology, Universidade Federal de Uberlândia (UFU), Uberlândia (MG), Brazil.
Sao Paulo Med J. 2023 May 12;141(6):e20210933. doi: 10.1590/1516-3180.2021.0933.R1.24022023. eCollection 2023.
Urinary tract infections (UTI) are highly preventable and have significant clinical and financial impact on the patient and the health care system.
To investigate UTIs in critically ill adult patients and the relationship of antimicrobial consumption and multidrug-resistant isolate.
A cohort study performed in a Brazilian tertiary-care university hospital in the city of Uberlandia (MG), located at the Federal University of Uberlandia, southeast region of the country.
We analyzed a cohort of 363 patients with first episode of UTIs from the adult intensive care unit (ICU), from January 2012 to December 2018. The daily doses of antimicrobial administered were calculated.
The incidence rate of UTI was 7.2/1000 patient days, with 3.5/1000 patient-days of bacteriuria, and 2.1/1000 patient-days of candiduria. Of 373 microorganisms identified, 69 (18.4%) were Gram-positive cocci, 190 (50.9%) Gram-negative bacilli, and 114 yeasts (30.7%). Escherichia coli and Candida spp. were the most common. Patients with candiduria had higher comorbidity score (Charlson Comorbidity Index ≥ 3), longer length of stay (P = 0.0066), higher mortality (P = < 0.0001) severe sepsis, septic shock, and were immunocompromised when compared with patients with bacteriuria. We observed correlation between antibiotics consumption and multidrug-resistant (MDR) microorganisms.
The UTIs incidence was high and was mainly caused by Gram-negative bacteria that were resistant to common antibiotics. We observed increase in the consumption of broad-spectrum antibiotics in ICU correlating with MDR microorganisms. In general, ICU-acquired candiduria may be associated with critical illness and poor prognosis.
尿路感染(UTI)是高度可预防的,对患者和医疗保健系统都有重大的临床和经济影响。
调查重症成年患者的尿路感染以及抗菌药物消耗与多重耐药分离株的关系。
在巴西米纳斯吉拉斯州联邦大学的乌贝兰迪亚市(MG)的一家三级保健大学医院进行了一项队列研究。
我们分析了 2012 年 1 月至 2018 年 12 月成人重症监护病房(ICU)首次发生 UTI 的 363 例患者的队列。计算了给予的抗菌药物日剂量。
UTI 的发病率为 7.2/1000 患者日,菌尿为 3.5/1000 患者日,念珠菌尿为 2.1/1000 患者日。在鉴定的 373 种微生物中,69 种(18.4%)为革兰氏阳性球菌,190 种(50.9%)为革兰氏阴性杆菌,114 种为酵母(30.7%)。大肠埃希氏菌和念珠菌属最为常见。与菌尿患者相比,念珠菌尿患者的合并症评分更高(Charlson 合并症指数≥3),住院时间更长(P = 0.0066),死亡率更高(P <0.0001),患有严重败血症、感染性休克且免疫功能低下。我们观察到抗生素消耗与多药耐药(MDR)微生物之间存在相关性。
UTI 的发病率很高,主要由对常用抗生素耐药的革兰氏阴性菌引起。我们观察到 ICU 中广谱抗生素的使用增加与 MDR 微生物相关。一般来说,ICU 获得性念珠菌尿可能与重病和不良预后有关。